Clinical trial NCT04623190: Using Health Information Technology to Improve Health Behaviors and Promote Cardiovascular Health Among Adolescent and Young Adult Cancer Survivors
Official title: Using Health Information Technology to Improve Health Behaviors and Promote Cardiovascular Health Among Adolescent and Young Adult Cancer Survivors
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Cardiovascular Disease
Young Adult Cancer Survivors
Lead sponsor: Washington University School of Medicine
Sponsor class: OTHER
Collaborators: name: American Cancer Society, Inc.
First posted: 2020-11-10
Enrollment: 26
Sex: ALL
Minimum age (years): 20
Maximum age (years): 39
Standard ages: ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: HEALTH_SERVICES_RESEARCH

Brief summary: Health information technology (HIT) has the potential to improve the quality, efficiency, consistency, and availability of cancer survivor care. PREVENT is a novel HIT tool designed by our team for adolescents (12-19 years). PREVENT aggregates and displays the American Heart Association's (AHA) Life Simple 7 cardiovascular health (CVH) risk factors and provides tailored, evidence-based, behavior change recommendations inclusive of community resources that are delivered to overweight/obese adolescents at the point-of-care to improve CVH. The investigators seek to expand this tool for patients beyond 19 years of age to increase this tool's reach to the entire adolescent and young adult (AYA) age range and then evaluate its effectiveness among AYA cancer survivors.


Eligibility criteria: Patient eligibility criteria

* Aged 20-39 years
* Prior diagnosis of pediatric cancer (diagnosed \<21 years of age).
* Not receiving active therapy for their cancer
* Receiving care from the Pediatric Hematology/Oncology staff and physicians at St. Louis Children's Hospital, the St. Louis Children's Specialty Care Center, Siteman Cancer Center's Lifelong Outcomes Clinic at Siteman South County
* At risk for poor CVH (BMI ≥ 25 kg/m\^2)
* Ability to understand and willingness to sign an IRB approved written informed consent document (or that of legally authorized representative, if applicable).

Provider eligibility criteria.

-All providers and clinic staff (physicians, nurses, clinic staff, clinic research associates) in the Pediatric Hematology/Oncology program at St. Louis Children's Hospital and the CSCC or in the Siteman Cancer Center's Lifelong Outcomes Clinic at Siteman South County are eligible to participate.

Primary outcomes:
measure: Change in minutes of physical activity
timeFrame: At baseline and 3-months
measure: Change in food intake behaviors
timeFrame: At baseline and 3-months
measure: Change in body mass index (BMI)
timeFrame: At baseline and 3-months
measure: Change on patient's attitudes toward behavior change
timeFrame: At baseline and 3-months
Secondary outcomes:
measure: Change in patients' satisfaction of PREVENT tool: survey
timeFrame: Within 48 hours of clinic visit and at 3-months
measure: Provider's satisfaction of PREVENT tool: survey
timeFrame: 3-months
measure: Change on patient's average systolic and diastolic blood pressure
timeFrame: At baseline and 3-months
measure: Change in patient's cholesterol
timeFrame: At baseline and 3-months
measure: Change in patient's fasting blood glucose
timeFrame: At baseline and 3-months
measure: Provider's motivation for sustained use of PREVENT tool
timeFrame: 3-months
measure: Fidelity of PREVENT tool implementation
timeFrame: 0-3 months
Other outcomes:
Locations:
city: Saint Louis
country: United States
facility: Washington University School of Medicine
state: Missouri
Study officials:
affiliation: Washington University School of Medicine
name: Maura Kepper, Ph.D.
role: PRINCIPAL_INVESTIGATOR
References: